Abstract
Anna Biernacka, Joanna P. Kacperczyk-Bartnik, Ewa Witkowska, Julia Foremniak, Mariusz Bidziński, Paweł Derlatka, Justyna Marynowska
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Advances and prospects in tumor infiltrating lymphocyte therapy
10.1007/s12672-024-01410-5 · 2024
Expansion of tumor-infiltrating lymphocytes from head and neck squamous cell carcinoma to assess the potential of adoptive cell therapy
10.1007/s00262-024-03691-9 · 2024
Development of an optimized closed and semi-automatic protocol for Good Manufacturing Practice manufacturing of tumor-infiltrating lymphocytes in a hospital environment
10.1016/j.jcyt.2020.07.011 · 2020
Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells
10.1007/s00262-018-2211-3 · 2018
Tumor-infiltrating lymphocytes: Streamlining a complex manufacturing process
10.1016/j.jcyt.2018.11.004 · 2019
10.3390/ijms20040952
10.3390/ijms20040952
10.3390/diagnostics15040406
10.3390/diagnostics15040406
10.1038/nature10166
10.1038/nature10166
Comprehensive genomic profiling of high-grade serous ovarian carcinoma from Chinese patients identifies co-occurring mutations in the Ras/Raf pathway with TP53
10.1002/cam4.2243 · 2019
Morphological and molecular basis of ovarian serous carcinoma
10.1016/s1674-8301(10)60036-x · 2010
Best Practices for Preparing a Single Cell Suspension from Solid Tissues for Flow Cytometry
10.1002/cyto.a.23690 · 2019
Phenotypic characterization and functional analysis of human tumor immune infiltration after mechanical and enzymatic disaggregation
10.1016/j.jim.2011.07.002 · 2011
An optimized disaggregation method for human lung tumors that preserves the phenotype and function of the immune cells
10.1189/jlb.5ta0814-373 · 2015
Dissociation of solid tumor tissues with cold active protease for single-cell RNA-seq minimizes conserved collagenase-associated stress responses
10.1186/s13059-019-1830-0 · 2019
Recent advancements in tissue dissociation techniques for cell manufacturing single-cell analysis and downstream processing
10.1093/stcltm/szaf055 · 2025
Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma
10.1016/j.ygyno.2007.10.016 · 2008
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
10.1056/nejmoa020177 · 2003
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
10.1073/pnas.0509182102 · 2005
Immunotherapy and the ovarian cancer microenvironment: Exploring potential strategies for enhanced treatment efficacy
10.1111/imm.13793 · 2024
Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis
10.1016/j.xcrm.2022.100856 · 2022
Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy
10.1038/s41588-020-0630-5 · 2020
Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer
10.1016/j.cell.2018.03.073 · 2018
Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient
10.1016/j.cell.2017.07.025 · 2017
The long noncoding RNA AC093895.1 promotes ovarian cancer formation and metastasis through a positive feedback network dependent on the transcription factor SOX4
10.1038/s41419-026-08429-2 · 2026
Single-cell sequencing reveals dissociation-induced gene expression in tissue subpopulations
10.1038/nmeth.4437 · 2017
Tissue Dissociation Enzymes for Adipose Stromal Vascular Fraction Cell Isolation: A Review
10.4172/2157-7633.1000321 · 2015
A single-cell landscape of high-grade serous ovarian cancer
10.1038/s41591-020-0926-0 · 2020
Single-cell transcriptomes reveal heterogeneity of high-grade serous ovarian carcinoma
10.1002/ctm2.500 · 2021
High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: Specific cell subtypes influence survival and determine molecular subtype classification
10.1186/s13073-021-00922-x · 2021
Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
10.1016/j.ygyno.2011.09.039 · 2012
Potential clinical application of tumor-infiltrating lymphocyte therapy for ovarian epithelial cancer prior or post-resistance to chemotherapy
10.1007/s00262-019-02402-z · 2019
Potential clinical application of tumor-infiltrating lymphocyte therapy for ovarian epithelial cancer prior or post-resistance to chemotherapy
10.1007/s00262-019-02402-z · doi-reference
Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
10.1016/j.ygyno.2011.09.039 · doi-reference
High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: Specific cell subtypes influence survival and determine molecular subtype classification
10.1186/s13073-021-00922-x · doi-reference
Single-cell transcriptomes reveal heterogeneity of high-grade serous ovarian carcinoma
10.1002/ctm2.500 · doi-reference
A single-cell landscape of high-grade serous ovarian cancer
10.1038/s41591-020-0926-0 · doi-reference
Tissue Dissociation Enzymes for Adipose Stromal Vascular Fraction Cell Isolation: A Review
10.4172/2157-7633.1000321 · doi-reference
Single-cell sequencing reveals dissociation-induced gene expression in tissue subpopulations
10.1038/nmeth.4437 · doi-reference
The long noncoding RNA AC093895.1 promotes ovarian cancer formation and metastasis through a positive feedback network dependent on the transcription factor SOX4
10.1038/s41419-026-08429-2 · doi-reference
Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient
10.1016/j.cell.2017.07.025 · doi-reference
Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer
10.1016/j.cell.2018.03.073 · doi-reference
Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy
10.1038/s41588-020-0630-5 · doi-reference
Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis
10.1016/j.xcrm.2022.100856 · doi-reference
Immunotherapy and the ovarian cancer microenvironment: Exploring potential strategies for enhanced treatment efficacy
10.1111/imm.13793 · doi-reference
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
10.1073/pnas.0509182102 · doi-reference
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
10.1056/nejmoa020177 · doi-reference
Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma
10.1016/j.ygyno.2007.10.016 · doi-reference
Recent advancements in tissue dissociation techniques for cell manufacturing single-cell analysis and downstream processing
10.1093/stcltm/szaf055 · doi-reference
Dissociation of solid tumor tissues with cold active protease for single-cell RNA-seq minimizes conserved collagenase-associated stress responses
10.1186/s13059-019-1830-0 · doi-reference
An optimized disaggregation method for human lung tumors that preserves the phenotype and function of the immune cells
10.1189/jlb.5ta0814-373 · doi-reference
Phenotypic characterization and functional analysis of human tumor immune infiltration after mechanical and enzymatic disaggregation
10.1016/j.jim.2011.07.002 · doi-reference
Best Practices for Preparing a Single Cell Suspension from Solid Tissues for Flow Cytometry
10.1002/cyto.a.23690 · doi-reference
Morphological and molecular basis of ovarian serous carcinoma
10.1016/s1674-8301(10)60036-x · doi-reference
Comprehensive genomic profiling of high-grade serous ovarian carcinoma from Chinese patients identifies co-occurring mutations in the Ras/Raf pathway with TP53
10.1002/cam4.2243 · doi-reference
10.1038/nature10166
10.1038/nature10166 · doi-reference
10.3390/diagnostics15040406
10.3390/diagnostics15040406 · doi-reference
10.3390/ijms20040952
10.3390/ijms20040952 · doi-reference
Tumor-infiltrating lymphocytes: Streamlining a complex manufacturing process
10.1016/j.jcyt.2018.11.004 · doi-reference
Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells
10.1007/s00262-018-2211-3 · doi-reference
Development of an optimized closed and semi-automatic protocol for Good Manufacturing Practice manufacturing of tumor-infiltrating lymphocytes in a hospital environment
10.1016/j.jcyt.2020.07.011 · doi-reference
Expansion of tumor-infiltrating lymphocytes from head and neck squamous cell carcinoma to assess the potential of adoptive cell therapy
10.1007/s00262-024-03691-9 · doi-reference
Advances and prospects in tumor infiltrating lymphocyte therapy
10.1007/s12672-024-01410-5 · doi-reference